Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Heartware Ltd (ASX:HTW)
since 2010 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Heartware Ltd.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1389072.
Total stock buying since 2010: $8,032,611.
Total stock sales since 2010: $280,407,818.
Total stock option exercises since 2010: $6,543,423.
Table 3. Detailed insider trading at Heartware Ltd (ASX:HTW) , Part 3
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2012-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,388 | 82.09 | 196,030 |
| 2012-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 5,612 | .00 | 0 |
| 2012-12-20 | Farrell Lauren (VP, Finance) | Sale | 243 | 82.08 | 19,945 |
| 2012-12-20 | Farrell Lauren (VP, Finance) | Option Ex | 750 | .00 | 0 |
| 2012-12-14 | Harrison Seth Loring (Director) | Sale | 75,922 | 81.06 | 6,153,857 |
| 2012-12-13 | Hathaway David R (Chief Medical Officer) | Sale | 5,640 | 81.10 | 457,403 |
| 2012-12-13 | Harrison Seth Loring (Director) | Sale | 108,571 | 81.69 | 8,869,164 |
| 2012-12-13 | Wade Denis Newell (Director) | Sale | 2,163 | 81.00 | 175,203 |
| 2012-12-12 | Hathaway David R (Chief Medical Officer) | Sale | 6,000 | 81.81 | 490,860 |
| 2012-12-12 | Harrison Seth Loring (Director) | Sale | 11,480 | 81.82 | 939,293 |
| 2012-12-12 | Wade Denis Newell (Director) | Sale | 337 | 82.50 | 27,802 |
| 2012-12-11 | Hathaway David R (Chief Medical Officer) | Sale | 6,000 | 82.17 | 493,020 |
| 2012-12-11 | Harrison Seth Loring (Director) | Sale | 55,358 | 82.18 | 4,549,320 |
| 2012-12-10 | Harrison Seth Loring (Director) | Sale | 25,500 | 83.03 | 2,117,265 |
| 2012-12-07 | Harrison Seth Loring (Director) | Sale | 48,130 | 80.92 | 3,894,438 |
| 2012-12-04 | Thomas Robert Bain (Director) | Sale | 3,600 | 80.36 | 289,296 |
| 2012-12-03 | Schuermann James (SVP, Sales & Marketing) | Sale | 2,500 | 81.64 | 204,100 |
| 2012-12-03 | Thomas Robert Bain (Director) | Sale | 1,400 | 80.60 | 112,839 |
| 2012-12-03 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,413 | 80.26 | 113,407 |
| 2012-11-21 | Schuermann James (SVP, Sales & Marketing) | Sale | 800 | 84.37 | 67,494 |
| 2012-11-21 | Larose Jeffrey (Chief Scientific Officer) | Sale | 909 | 84.37 | 76,690 |
| 2012-11-21 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,817 | 84.37 | 322,032 |
| 2012-11-21 | Farrell Lauren (VP, Finance) | Sale | 536 | 84.74 | 45,420 |
| 2012-11-20 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 1,786 | .00 | 0 |
| 2012-11-20 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 2,322 | .00 | 0 |
| 2012-11-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 8,572 | .00 | 0 |
| 2012-11-20 | Farrell Lauren (VP, Finance) | Option Ex | 536 | .00 | 0 |
| 2012-11-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 84.01 | 84,010 |
| 2012-09-18 | Hathaway David R (Chief Medical Officer) | Sale | 916 | 92.39 | 84,629 |
| 2012-09-18 | Schuermann James (SVP, Sales & Marketing) | Sale | 915 | 92.39 | 84,536 |
| 2012-09-18 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,200 | 92.39 | 110,868 |
| 2012-09-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 11,162 | 92.52 | 1,032,708 |
| 2012-09-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 7,500 | 40.48 | 303,600 |
| 2012-09-18 | Farrell Lauren (VP, Finance) | Sale | 69 | 92.39 | 6,374 |
| 2012-09-17 | Hathaway David R (Chief Medical Officer) | Sale | 3,338 | 92.09 | 307,396 |
| 2012-09-17 | Schuermann James (SVP, Sales & Marketing) | Sale | 3,339 | 92.09 | 307,505 |
| 2012-09-17 | Larose Jeffrey (Chief Scientific Officer) | Sale | 4,377 | 92.09 | 403,077 |
| 2012-09-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 13,352 | 92.09 | 1,229,652 |
| 2012-09-17 | Farrell Lauren (VP, Finance) | Sale | 255 | 92.08 | 23,481 |
| 2012-09-16 | Hathaway David R (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
| 2012-09-16 | Schuermann James (SVP, Sales & Marketing) | Option Ex | 10,000 | .00 | 0 |
| 2012-09-16 | Larose Jeffrey (Chief Scientific Officer) | Option Ex | 15,000 | .00 | 0 |
| 2012-09-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 40,000 | .00 | 0 |
| 2012-09-16 | Farrell Lauren (VP, Finance) | Option Ex | 1,000 | .00 | 0 |
| 2012-08-28 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,146 | 90.24 | 283,895 |
| 2012-08-28 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 3,146 | 40.01 | 125,871 |
| 2012-08-24 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 1,854 | 90.09 | 167,026 |
| 2012-08-24 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 1,854 | 40.38 | 74,864 |
| 2012-08-23 | Thomas Robert Bain (Director) | Sale | 5,000 | 88.80 | 444,000 |
| 2012-08-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 88.98 | 222,450 |
| 2012-08-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 2,500 | 40.41 | 101,024 |
| 2012-08-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 89.04 | 89,040 |
| 2012-07-31 | Larkin C Raymond Jr (Director) | Option Ex | 562 | .00 | 0 |
| 2012-07-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 7,500 | 90.67 | 680,025 |
| 2012-07-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 7,500 | 39.38 | 295,350 |
| 2012-07-16 | Harrison Seth Loring (Director) | Sale | 19,401 | 90.21 | 1,750,164 |
| 2012-07-13 | Harrison Seth Loring (Director) | Sale | 9,199 | 90.00 | 827,910 |
| 2012-07-12 | Harrison Seth Loring (Director) | Sale | 194 | 90.00 | 17,460 |
| 2012-07-03 | Harrison Seth Loring (Director) | Sale | 525 | 90.00 | 47,250 |
| 2012-07-02 | Schuermann James (VP, Sales & Marketing) | Sale | 1,000 | 90.00 | 90,000 |
| 2012-07-02 | Harrison Seth Loring (Director) | Sale | 700 | 90.00 | 63,000 |
| 2012-07-02 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 5,000 | 90.00 | 450,000 |
| 2012-07-02 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 5,000 | 39.41 | 197,049 |
| 2012-06-25 | Yocher Robert E (SVP, Regulatory & Quality) | Sale | 1,060 | 86.41 | 91,594 |
| 2012-06-23 | Yocher Robert E (SVP, Regulatory & Quality) | Option Ex | 2,500 | .00 | 0 |
| 2012-06-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 85.81 | 214,525 |
| 2012-06-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 2,500 | 38.81 | 97,025 |
| 2012-06-13 | Thomas Robert Bain (Director) | Sale | 714 | 85.24 | 60,861 |
| 2012-06-12 | Thomas Robert Bain (Director) | Sale | 5,000 | 85.61 | 428,050 |
| 2012-06-08 | Schuermann James (VP, Sales & Marketing) | Sale | 1,000 | 85.00 | 85,000 |
| 2012-06-07 | Stockman Robert Bernard (Director) | Sale | 3,025 | 82.61 | 249,895 |
| 2012-05-25 | Thomas Robert Bain (Director) | Sale | 5,428 | 78.92 | 430,065 |
| 2012-05-23 | Thomas Robert Bain (Director) | Sale | 957 | 78.34 | 74,971 |
| 2012-05-21 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 1,322 | 79.83 | 105,535 |
| 2012-05-18 | Thomas Robert Bain (Director) | Sale | 6,429 | 78.67 | 505,737 |
| 2012-05-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 80.23 | 200,575 |
| 2012-05-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 2,500 | 38.20 | 95,500 |
| 2012-05-16 | Thomas Robert Bain (Director) | Sale | 5,000 | 80.00 | 400,000 |
| 2012-05-15 | Thomas Robert Bain (Director) | Sale | 5,000 | 80.73 | 403,650 |
| 2012-05-12 | Harrison Seth Loring (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-12 | Bennett Christine Constance (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-12 | Wade Denis Newell (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-12 | Stockman Robert Bernard (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-12 | Thomas Robert Bain (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-12 | Barberich Timothy J (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-12 | Larkin C Raymond Jr (Director) | Option Ex | 250 | .00 | 0 |
| 2012-05-11 | Farrell Lauren (VP, Finance) | Sale | 475 | 81.73 | 38,821 |
| 2012-05-09 | Schuermann James (VP, Sales & Marketing) | Sale | 313 | 77.18 | 24,157 |
| 2012-05-09 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 820 | 77.18 | 63,287 |
| 2012-05-09 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,445 | 77.18 | 265,885 |
| 2012-05-09 | Farrell Lauren (VP, Finance) | Sale | 239 | 77.18 | 18,446 |
| 2012-05-08 | Schuermann James (VP, Sales & Marketing) | Option Ex | 714 | .00 | 0 |
| 2012-05-08 | Larose Jeffrey (Chief Scientifc Officer) | Option Ex | 2,142 | .00 | 0 |
| 2012-05-08 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 7,857 | .00 | 0 |
| 2012-05-08 | Farrell Lauren (VP, Finance) | Option Ex | 714 | .00 | 0 |
| 2012-05-04 | Harrison Seth Loring (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-04 | Bennett Christine Constance (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-04 | Wade Denis Newell (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-04 | Stockman Robert Bernard (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-04 | Thomas Robert Bain (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-04 | Barberich Timothy J (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-04 | Larkin C Raymond Jr (Director) | Option Ex | 333 | .00 | 0 |
| 2012-05-01 | Schuermann James (VP, Sales & Marketing) | Sale | 2,500 | 78.60 | 196,500 |
| 2012-04-26 | Harrison Seth Loring (Director) | Sale | 30,019 | 78.04 | 2,342,682 |
| 2012-04-26 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 77.59 | 193,975 |
| 2012-04-26 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 2,500 | 39.94 | 99,850 |
| 2012-04-26 | Farrell Lauren (VP, Finance) | Sale | 1,286 | 78.00 | 100,308 |
| 2012-04-26 | Farrell Lauren (VP, Finance) | Option Ex | 1,286 | 25.31 | 32,544 |
| 2012-03-28 | Knopf Lawrence J (General Counsel) | Sale | 2,258 | 67.46 | 152,324 |
| 2012-03-28 | Knopf Lawrence J (General Counsel) | Option Ex | 5,250 | .00 | 0 |
| 2012-03-06 | Thomas Robert Bain (Director) | Sale | 5,999 | 71.37 | 428,130 |
| 2012-02-28 | Wade Denis Newell (Director) | Sale | 6,000 | 74.50 | 447,000 |
| 2012-02-27 | Wade Denis Newell (Director) | Sale | 12,000 | 73.75 | 885,000 |
| 2012-02-27 | Thomas Robert Bain (Director) | Sale | 595 | 72.97 | 43,411 |
| 2012-02-24 | Wade Denis Newell (Director) | Sale | 6,000 | 73.50 | 441,000 |
| 2012-02-24 | Thomas Robert Bain (Director) | Sale | 1,376 | 74.00 | 101,824 |
| 2012-02-23 | Thomas Robert Bain (Director) | Sale | 1,000 | 74.00 | 74,000 |
| 2012-02-22 | Wade Denis Newell (Director) | Sale | 6,000 | 74.00 | 444,000 |
| 2012-02-21 | Thomas Robert Bain (Director) | Sale | 571 | 73.88 | 42,182 |
| 2012-02-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,918 | 75.24 | 294,802 |
| 2012-02-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 1,620 | 41.19 | 66,727 |
| 2012-02-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 75.00 | 187,500 |
| 2012-02-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 2,500 | 41.29 | 103,225 |
| 2012-02-16 | Farrell Lauren (VP, Finance) | Sale | 600 | 75.00 | 45,000 |
| 2012-02-01 | Schuermann James (VP, Sales & Marketing) | Sale | 1,000 | 69.13 | 69,130 |
| 2012-01-31 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 5,000 | 70.07 | 350,349 |
| 2012-01-06 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,850 | 70.74 | 272,349 |
| 2012-01-06 | Farrell Lauren (VP, Finance) | Sale | 499 | 72.00 | 35,928 |
| 2012-01-05 | Schuermann James (VP, Sales & Marketing) | Sale | 808 | 70.00 | 56,560 |
| 2012-01-05 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 1,150 | 70.08 | 80,592 |
| 2012-01-03 | Schuermann James (VP, Sales & Marketing) | Sale | 192 | 70.00 | 13,440 |
| 2012-01-03 | Farrell Lauren (VP, Finance) | Sale | 672 | 70.00 | 47,040 |
| 2011-12-20 | Hathaway David R (Chief Medical Officer) | Sale | 554 | 68.44 | 37,918 |
| 2011-12-20 | Hathaway David R (Chief Medical Officer) | Option Ex | 1,263 | .00 | 0 |
| 2011-12-20 | Schuermann James (VP, Sales & Marketing) | Sale | 548 | 68.44 | 37,505 |
| 2011-12-20 | Schuermann James (VP, Sales & Marketing) | Option Ex | 1,250 | .00 | 0 |
| 2011-12-20 | Mcintyre David (CFO & COO) | Sale | 3,125 | 68.44 | 213,890 |
| 2011-12-20 | Mcintyre David (CFO & COO) | Option Ex | 3,125 | .00 | 0 |
| 2011-12-20 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 1,072 | 68.44 | 73,373 |
| 2011-12-20 | Larose Jeffrey (Chief Scientifc Officer) | Option Ex | 2,800 | .00 | 0 |
| 2011-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,461 | 68.44 | 168,443 |
| 2011-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 5,613 | .00 | 0 |
| 2011-12-20 | Farrell Lauren (VP, Finance) | Sale | 251 | 68.44 | 17,178 |
| 2011-12-20 | Farrell Lauren (VP, Finance) | Option Ex | 750 | .00 | 0 |
| 2011-12-19 | Mcintyre David (CFO & COO) | Sale | 7,337 | 68.71 | 504,125 |
| 2011-12-19 | Mcintyre David (CFO & COO) | Option Ex | 5,714 | 38.41 | 219,474 |
| 2011-12-13 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 800 | 70.00 | 56,000 |
| 2011-12-09 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 6,505 | 70.09 | 455,935 |
| 2011-12-07 | Schuermann James (VP, Sales & Marketing) | Sale | 4,000 | 68.56 | 274,260 |
| 2011-12-01 | Thomas Robert Bain (Director) | Sale | 2,500 | 68.13 | 170,325 |
| 2011-11-17 | Thomas Robert Bain (Director) | Sale | 2,500 | 62.45 | 156,125 |
| 2011-11-16 | Thomas Robert Bain (Director) | Sale | 2,500 | 63.57 | 158,925 |
| 2011-11-15 | Thomas Robert Bain (Director) | Sale | 2,500 | 63.97 | 159,925 |
| 2011-10-06 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 294 | 70.09 | 20,606 |
| 2011-10-05 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 6,500 | 70.04 | 455,260 |
| 2011-09-19 | Paz Ramon (VP, Quality Assurance) | Sale | 5,143 | 54.77 | 281,682 |
| 2011-09-19 | Mcintyre David (CFO & COO) | Sale | 16,168 | 54.90 | 887,542 |
| 2011-09-19 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 776 | 55.02 | 42,695 |
| 2011-09-19 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,372 | 55.02 | 130,507 |
| 2011-09-16 | Hathaway David R (Chief Medical Officer) | Sale | 4,384 | 55.05 | 241,339 |
| 2011-09-16 | Hathaway David R (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
| 2011-09-16 | Paz Ramon (VP, Quality Assurance) | Sale | 3,190 | 55.05 | 175,609 |
| 2011-09-16 | Paz Ramon (VP, Quality Assurance) | Option Ex | 8,333 | .00 | 0 |
| 2011-09-16 | Schuermann James (VP, Sales & Marketing) | Sale | 4,384 | 55.05 | 241,339 |
| 2011-09-16 | Schuermann James (VP, Sales & Marketing) | Option Ex | 10,000 | .00 | 0 |
| 2011-09-16 | Mcintyre David (CFO & COO) | Sale | 7,999 | 55.44 | 443,488 |
| 2011-09-16 | Mcintyre David (CFO & COO) | Option Ex | 24,167 | .00 | 0 |
| 2011-09-16 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 4,965 | 55.44 | 275,274 |
| 2011-09-16 | Larose Jeffrey (Chief Scientifc Officer) | Option Ex | 15,000 | .00 | 0 |
| 2011-09-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 15,163 | 55.44 | 840,682 |
| 2011-09-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 40,000 | .00 | 0 |
| 2011-09-16 | Farrell Lauren (VP, Finance) | Sale | 334 | 55.05 | 18,386 |
| 2011-09-16 | Farrell Lauren (VP, Finance) | Option Ex | 1,000 | .00 | 0 |
| 2011-09-09 | Thomas Robert Bain (Director) | Sale | 5,000 | 58.65 | 293,250 |
| 2011-09-06 | Thomas Robert Bain (Director) | Sale | 5,000 | 60.35 | 301,750 |
| 2011-08-31 | Thomas Robert Bain (Director) | Sale | 5,000 | 63.27 | 316,350 |
| 2011-08-23 | Stockman Robert Bernard (Director) | Buy | 1,500 | 60.42 | 90,630 |
| 2011-06-23 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 10,000 | 71.31 | 713,100 |
| 2011-05-25 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 1,428 | 70.97 | 101,345 |
| 2011-05-19 | Thomas Robert Bain (Director) | Sale | 5,000 | 76.16 | 380,800 |
| 2011-05-18 | Thomas Robert Bain (Director) | Sale | 143 | 75.47 | 10,792 |
| 2011-05-16 | Barberich Timothy J (Director) | Buy | 2,500 | 78.18 | 195,450 |
| 2011-05-04 | Harrison Seth Loring (Director) | Option Ex | 334 | .00 | 0 |
| 2011-05-04 | Bennett Christine Constance (Director) | Option Ex | 334 | .00 | 0 |
| 2011-05-04 | Wade Denis Newell (Director) | Option Ex | 334 | .00 | 0 |
| 2011-05-04 | Stockman Robert Bernard (Director) | Option Ex | 334 | .00 | 0 |
| 2011-05-04 | Thomas Robert Bain (Director) | Option Ex | 334 | .00 | 0 |
| 2011-05-04 | Barberich Timothy J (Director) | Option Ex | 334 | .00 | 0 |
| 2011-05-04 | Larkin C Raymond Jr (Director) | Option Ex | 334 | .00 | 0 |
| 2011-02-23 | Farrell Lauren (VP, Finance) | Sale | 985 | 86.64 | 85,340 |
| 2011-02-22 | Paz Ramon (VP, Quality Assurance) | Sale | 1,429 | 87.70 | 125,323 |
| 2011-02-22 | Paz Ramon (VP, Quality Assurance) | Option Ex | 1,429 | .00 | 0 |
| 2011-02-22 | Schuermann James (VP, Sales & Marketing) | Sale | 788 | 87.70 | 69,107 |
| 2011-02-22 | Schuermann James (VP, Sales & Marketing) | Option Ex | 1,785 | .00 | 0 |
| 2011-02-22 | Mcintyre David (CFO & COO) | Sale | 2,857 | 87.70 | 250,558 |
| 2011-02-22 | Mcintyre David (CFO & COO) | Option Ex | 2,857 | .00 | 0 |
| 2011-02-22 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 893 | 87.70 | 78,316 |
| 2011-02-22 | Larose Jeffrey (Chief Scientifc Officer) | Option Ex | 2,321 | .00 | 0 |
| 2011-02-22 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,759 | 87.70 | 329,664 |
| 2011-02-22 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 8,571 | .00 | 0 |
| 2011-02-22 | Farrell Lauren (VP, Finance) | Sale | 179 | 87.69 | 15,696 |
| 2011-02-22 | Farrell Lauren (VP, Finance) | Option Ex | 535 | .00 | 0 |
| 2011-01-25 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 10,000 | 92.51 | 925,100 |
| 2011-01-25 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 10,000 | 38.07 | 380,700 |
| 2011-01-11 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 1,400 | 99.00 | 138,600 |
| 2011-01-11 | Larose Jeffrey (Chief Scientifc Officer) | Option Ex | 1,400 | 17.38 | 24,332 |
| 2011-01-03 | Paz Ramon (VP, Quality Assurance) | Sale | 5,612 | 85.90 | 482,070 |
| 2011-01-03 | Paz Ramon (VP, Quality Assurance) | Option Ex | 72 | 39.37 | 2,834 |
| 2011-01-03 | Farrell Lauren (VP, Finance) | Sale | 1,072 | 86.55 | 92,781 |
| 2011-01-03 | Farrell Lauren (VP, Finance) | Option Ex | 1,072 | 39.37 | 42,204 |
| 2010-12-17 | Thomas Robert Bain (Director) | Sale | 10,000 | 86.61 | 866,100 |
| 2010-12-09 | Harrison Seth Loring (Director) | Sale | 1,000,000 | 77.86 | 77,855,000 |
| 2010-12-09 | Apple Tree Partners I Lp (10% Owner) | Sale | 1,000,000 | 77.86 | 77,855,000 |
| 2010-09-17 | Hathaway David R (Chief Medical Officer) | Sale | 4,431 | 71.33 | 316,063 |
| 2010-09-17 | Paz Ramon (VP, Quality Assurance) | Sale | 1,422 | 71.42 | 101,559 |
| 2010-09-17 | Schuermann James (VP, Sales & Marketing) | Sale | 1,981 | 71.36 | 141,364 |
| 2010-09-17 | Mcintyre David (CFO & COO) | Sale | 11,602 | 71.36 | 827,918 |
| 2010-09-17 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 7,200 | 71.36 | 513,792 |
| 2010-09-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 7,952 | 71.35 | 567,375 |
| 2010-09-17 | Farrell Lauren (VP, Finance) | Sale | 1,285 | 71.39 | 91,736 |
| 2010-09-16 | Hathaway David R (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
| 2010-09-16 | Paz Ramon (VP, Quality Assurance) | Sale | 1,800 | 71.42 | 128,556 |
| 2010-09-16 | Paz Ramon (VP, Quality Assurance) | Option Ex | 8,334 | .00 | 0 |
| 2010-09-16 | Schuermann James (VP, Sales & Marketing) | Sale | 2,450 | 71.50 | 175,175 |
| 2010-09-16 | Schuermann James (VP, Sales & Marketing) | Option Ex | 10,000 | .00 | 0 |
| 2010-09-16 | Mcintyre David (CFO & COO) | Sale | 12,565 | 71.42 | 897,329 |
| 2010-09-16 | Mcintyre David (CFO & COO) | Option Ex | 24,167 | .00 | 0 |
| 2010-09-16 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 7,800 | 71.42 | 557,115 |
| 2010-09-16 | Larose Jeffrey (Chief Scientifc Officer) | Option Ex | 15,000 | .00 | 0 |
| 2010-09-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 9,750 | 71.41 | 696,247 |
| 2010-09-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Ex | 40,000 | .00 | 0 |
| 2010-09-16 | Farrell Lauren (VP, Finance) | Sale | 750 | 73.75 | 55,312 |
| 2010-09-16 | Farrell Lauren (VP, Finance) | Option Ex | 2,285 | 15.56 | 35,561 |
| 2010-07-31 | Larkin C Raymond Jr (Director) | Option Ex | 562 | .00 | 0 |
| 2010-06-16 | Farrell Lauren (VP, Finance) | Sale | 4,818 | 66.73 | 321,505 |
| 2010-06-15 | Farrell Lauren (VP, Finance) | Option Ex | 4,818 | 24.00 | 115,646 |
| 2010-06-10 | Thomas Robert Bain (Director) | Sale | 857 | 59.99 | 51,411 |
| 2010-06-04 | Paz Ramon (VP, Quality Assurance) | Sale | 5,927 | 61.35 | 363,621 |
| 2010-06-04 | Paz Ramon (VP, Quality Assurance) | Option Ex | 5,927 | 27.00 | 159,999 |
| 2010-05-24 | Paz Ramon (VP, Quality Assurance) | Sale | 2,646 | 54.77 | 144,921 |
| 2010-05-19 | Thomas Robert Bain (Director) | Sale | 328 | 56.93 | 18,673 |
| 2010-05-18 | Thomas Robert Bain (Director) | Sale | 1,242 | 54.16 | 67,272 |
| 2010-05-17 | Thomas Robert Bain (Director) | Sale | 429 | 52.18 | 22,385 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ASX:HTW listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Heartware Ltd (symbol ASX:HTW,
CIK number 1389072) see
the Securities and Exchange Commission (SEC) website.